| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |